Exousia Bio (LMMY) Total Liabilities (2022 - 2025)
Lamy (LMMY) has disclosed Total Liabilities for 4 consecutive years, with $261023.0 as the latest value for Q4 2025.
- Quarterly Total Liabilities changed N/A to $261023.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $261023.0 through Nov 2025, changed N/A year-over-year, with the annual reading at $82348.0 for FY2024, 24.52% up from the prior year.
- Total Liabilities hit $261023.0 in Q4 2025 for Lamy, up from $35314.0 in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $261023.0 in Q4 2025 to a low of $13408.0 in Q3 2022.
- Historically, Total Liabilities has averaged $77013.0 across 4 years, with a median of $68081.0 in 2023.
- Biggest five-year swings in Total Liabilities: surged 407.76% in 2023 and later tumbled 59.3% in 2025.
- Year by year, Total Liabilities stood at $21814.0 in 2022, then skyrocketed by 228.06% to $71564.0 in 2023, then increased by 21.24% to $86764.0 in 2024, then soared by 200.84% to $261023.0 in 2025.
- Business Quant data shows Total Liabilities for LMMY at $261023.0 in Q4 2025, $35314.0 in Q3 2025, and $86764.0 in Q3 2024.